CEACAM5 and gastric adenocarcinoma: These serum biomarkers include carcinoembryonic antigen (CEA) [7], which is increased in the serum of gastric adenocarcinoma patients, but not during the early stages of carcinogenesis, and thus is not a useful marker of early disease [8].